FAIR ISAAC CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FAIR ISAAC CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2020 | $374.36M | Nov 12, 2020 |
| FY2019 | Jun 30, 2020 | $313.73M | Nov 12, 2020 |
| FY2019 | Mar 31, 2020 | $307.97M | Nov 12, 2020 |
| FY2019 | Dec 31, 2019 | $298.50M | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | $305.34M | Nov 12, 2020 |
| FY2019 | Jun 30, 2019 | $314.25M | Nov 12, 2020 |
| FY2019 | Mar 31, 2019 | $278.23M | Nov 12, 2020 |
| FY2019 | Dec 31, 2018 | $262.26M | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $256.53M | Nov 8, 2019 |
| FY2019 | Jun 30, 2018 | $254.99M | Nov 8, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.99B | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $1.72B | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $1.51B | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $1.38B | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $1.32B | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $1.29B | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $1.16B | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $1.00B | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $934.98M | Nov 8, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $253.21M | Nov 9, 2017 |
| FY2017 | Jun 30, 2017 | $230.99M | Nov 9, 2017 |
| FY2017 | Mar 31, 2017 | $228.38M | Nov 9, 2017 |
| FY2017 | Dec 31, 2016 | $219.60M | Nov 9, 2017 |
| FY2017 | Sep 30, 2016 | $235.82M | Nov 9, 2017 |
| FY2017 | Jun 30, 2016 | $238.78M | Nov 9, 2017 |
| FY2017 | Mar 31, 2016 | $206.68M | Nov 9, 2017 |
| FY2017 | Dec 31, 2015 | $200.08M | Nov 9, 2017 |
| FY2016 | Sep 30, 2015 | $232.76M | Nov 10, 2016 |
| FY2016 | Jun 30, 2015 | $209.37M | Nov 10, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2020 | $280.68M | Nov 12, 2020 |
| FY2019 | Jun 30, 2020 | $225.16M | Nov 12, 2020 |
| FY2019 | Mar 31, 2020 | $219.83M | Nov 12, 2020 |
| FY2019 | Dec 31, 2019 | $207.75M | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | $217.35M | Nov 12, 2020 |
| FY2019 | Jun 30, 2019 | $227.03M | Nov 12, 2020 |
| FY2019 | Mar 31, 2019 | $192.67M | Nov 12, 2020 |
| FY2019 | Dec 31, 2018 | $186.19M | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $176.57M | Nov 8, 2019 |
| FY2019 | Jun 30, 2018 | $175.98M | Nov 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $651.95M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $512.81M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $429.38M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $373.54M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $392.08M | Nov 8, 2023 |
| FY2019 | Sep 30, 2020 | $59.13M | Nov 12, 2020 |
| FY2019 | Jun 30, 2020 | $64.08M | Nov 12, 2020 |
| FY2019 | Mar 31, 2020 | $58.29M | Nov 12, 2020 |
| FY2019 | Dec 31, 2019 | $54.92M | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | $54.58M | Nov 12, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $924.85M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $733.63M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $642.83M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $542.41M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $505.49M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $295.97M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $253.55M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $175.36M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $182.16M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $169.59M | Nov 9, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $188.35M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $171.94M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $159.95M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $146.76M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $171.23M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $166.50M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $149.48M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $128.38M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $110.87M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $103.67M | Nov 9, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $513.03M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $462.83M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $400.57M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $383.86M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $396.28M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $420.93M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $414.09M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $376.91M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $337.17M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $328.94M | Nov 9, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $778.81M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $632.96M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $468.92M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $509.45M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $423.82M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $364.92M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $260.35M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $223.05M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $225.64M | Nov 8, 2019 |
| FY2012 | Sep 30, 2012 | $129.75M | Nov 16, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $8.92M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $8.88M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $4.24M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $6.03M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $7.57M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $21.99M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $23.98M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $31.30M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $19.83M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $21.97M | Nov 9, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.87B | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $1.72B | Nov 7, 2025 |
| FY2024 | Sep 30, 2023 | $1.58B | Nov 6, 2024 |
| FY2023 | Sep 30, 2022 | $1.44B | Nov 8, 2023 |
| FY2022 | Sep 30, 2021 | $1.57B | Nov 9, 2022 |
| FY2021 | Sep 30, 2020 | $1.61B | Nov 10, 2021 |
| FY2019 | Sep 30, 2019 | $1.43B | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $1.33B | Nov 8, 2019 |
| FY2018 | Sep 30, 2017 | $1.26B | Nov 9, 2018 |
| FY2017 | Sep 30, 2016 | $1.22B | Nov 9, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.61B | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $2.68B | Nov 7, 2025 |
| FY2024 | Sep 30, 2023 | $2.26B | Nov 6, 2024 |
| FY2023 | Sep 30, 2022 | $2.24B | Nov 8, 2023 |
| FY2022 | Sep 30, 2021 | $1.68B | Nov 9, 2022 |
| FY2021 | Sep 30, 2020 | $1.28B | Nov 10, 2021 |
| FY2019 | Sep 30, 2019 | $1.14B | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $1.04B | Nov 8, 2019 |
| FY2018 | Sep 30, 2017 | $829.08M | Nov 9, 2018 |
| FY2017 | Sep 30, 2016 | $773.85M | Nov 9, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($1.75B) | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | ($962.68M) | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | ($687.99M) | Nov 7, 2025 |
| FY2025 | Sep 30, 2022 | ($801.95M) | Nov 7, 2025 |
| FY2024 | Sep 30, 2021 | ($110.94M) | Nov 6, 2024 |
| FY2023 | Sep 30, 2020 | $331.08M | Nov 8, 2023 |
| FY2022 | Sep 30, 2019 | $289.77M | Nov 9, 2022 |
| FY2021 | Sep 30, 2018 | $287.44M | Nov 10, 2021 |
| FY2019 | Sep 30, 2017 | $466.18M | Nov 12, 2020 |
| FY2019 | Sep 30, 2016 | $481.32M | Nov 8, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $783.34M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $782.75M | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | $773.33M | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | $761.07M | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | $788.19M | Nov 8, 2023 |
| FY2022 | Sep 30, 2020 | $812.36M | Nov 9, 2022 |
| FY2021 | Sep 30, 2019 | $803.54M | Nov 10, 2021 |
| FY2019 | Sep 30, 2018 | $800.89M | Nov 12, 2020 |
| FY2019 | Sep 30, 2017 | $804.41M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $798.42M | Nov 9, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.55B | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $3.90B | Nov 7, 2025 |
| FY2024 | Sep 30, 2023 | $3.39B | Nov 6, 2024 |
| FY2023 | Sep 30, 2022 | $2.96B | Nov 8, 2023 |
| FY2022 | Sep 30, 2021 | $2.59B | Nov 9, 2022 |
| FY2021 | Sep 30, 2020 | $2.19B | Nov 10, 2021 |
| FY2019 | Sep 30, 2019 | $1.96B | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $1.76B | Nov 8, 2019 |
| FY2018 | Sep 30, 2017 | $1.60B | Nov 9, 2018 |
| FY2017 | Sep 30, 2016 | $1.47B | Nov 9, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $134.14M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $150.67M | Nov 7, 2025 |
| FY2024 | Sep 30, 2023 | $136.78M | Nov 6, 2024 |
| FY2023 | Sep 30, 2022 | $133.20M | Nov 8, 2023 |
| FY2022 | Sep 30, 2021 | $195.35M | Nov 9, 2022 |
| FY2021 | Sep 30, 2020 | $157.39M | Nov 10, 2021 |
| FY2019 | Sep 30, 2019 | $106.43M | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | $90.02M | Nov 8, 2019 |
| FY2019 | Sep 30, 2017 | $105.62M | Nov 8, 2019 |
| FY2019 | Sep 30, 2016 | $75.93M | Nov 8, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.06B | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | $2.21B | Nov 7, 2025 |
| FY2021 | Sep 30, 2021 | $750.00M | Nov 10, 2021 |
| FY2019 | Sep 30, 2020 | $750.00M | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | $485.00M | Nov 8, 2019 |
| FY2018 | Sep 30, 2018 | $513.00M | Nov 9, 2018 |
| FY2017 | Sep 30, 2017 | $244.00M | Nov 9, 2017 |
| FY2016 | Sep 30, 2016 | $316.00M | Nov 10, 2016 |
| FY2015 | Sep 30, 2015 | $376.00M | Nov 10, 2015 |
| FY2014 | Sep 30, 2014 | $447.00M | Nov 10, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 26 | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | 20 | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | 17 | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | 14 | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | 13 | Nov 8, 2023 |
| FY2019 | Sep 30, 2020 | 2 | Nov 12, 2020 |
| FY2019 | Jun 30, 2020 | 2 | Nov 12, 2020 |
| FY2019 | Mar 31, 2020 | 2 | Nov 12, 2020 |
| FY2019 | Dec 31, 2019 | 1 | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Nov 12, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 26 | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | 20 | Nov 7, 2025 |
| FY2025 | Sep 30, 2023 | 16 | Nov 7, 2025 |
| FY2024 | Sep 30, 2022 | 14 | Nov 6, 2024 |
| FY2023 | Sep 30, 2021 | 13 | Nov 8, 2023 |
| FY2019 | Sep 30, 2020 | 1 | Nov 12, 2020 |
| FY2019 | Jun 30, 2020 | 2 | Nov 12, 2020 |
| FY2019 | Mar 31, 2020 | 1 | Nov 12, 2020 |
| FY2019 | Dec 31, 2019 | 1 | Nov 12, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Nov 12, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 23.76M | Nov 7, 2025 |
| FY2025 | Sep 30, 2024 | 24.39M | Nov 7, 2025 |
| FY2024 | Sep 30, 2023 | 24.77M | Nov 6, 2024 |
| FY2023 | Sep 30, 2022 | 25.15M | Nov 8, 2023 |
| FY2022 | Sep 30, 2021 | 27.57M | Nov 9, 2022 |
| FY2021 | Sep 30, 2020 | 29.10M | Nov 10, 2021 |
| FY2019 | Sep 30, 2019 | 28.94M | Nov 12, 2020 |
| FY2019 | Sep 30, 2018 | 29.02M | Nov 8, 2019 |
| FY2018 | Sep 30, 2017 | 30.24M | Nov 9, 2018 |
| FY2017 | Sep 30, 2016 | 30.94M | Nov 9, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2019 | $0 | Nov 8, 2019 |
| FY2019 | Sep 30, 2018 | $0 | Nov 8, 2019 |
| FY2019 | Sep 30, 2017 | $1.24M | Nov 8, 2019 |
| FY2018 | Sep 30, 2016 | $2.49M | Nov 9, 2018 |
| FY2017 | Sep 30, 2015 | $2.51M | Nov 9, 2017 |
| FY2016 | Sep 30, 2014 | $2.71M | Nov 10, 2016 |
| FY2015 | Sep 30, 2013 | $2.82M | Nov 10, 2015 |
| FY2014 | Sep 30, 2012 | $2.80M | Nov 10, 2014 |
| FY2013 | Sep 30, 2011 | $3.14M | Nov 12, 2013 |
| FY2012 | Sep 30, 2010 | $3.58M | Nov 16, 2012 |